Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With Chronic Idiopathic Thrombocytopenic Purpura (ITP)

Clinical trial NCT00441090 · COMPLETED

Trial details

NCT number: NCT00441090
Sponsor: Eisai Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Idiopathic Thrombocytopenic Purpura Purpura, Thrombocytopenic, Idiopathic

Start date: 2007-02-01
Primary completion: 2009-01-01
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.